Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study

Cancer Causes and Control

Volumn 22, Issue 2, 2011, Pages 291-299

  Borena, Wegene ^a   Stocks, Tanja ^b   Jonsson, Håkan ^b   Strohmaier, Susanne ^a   Nagel, Gabriele ^c   Bjørge, Tone ^d,e   Manjer, Jonas ^f   Hallmans, Göran ^b   Selmer, Randi ^e   Almquist, Martin ^f   Häggström, Christel ^b   Engeland, Anders ^d,e   Tretli, Steinar ^g   Concin, Hans ^h   Strasak, Alexander ^a   Stattin, Pär ^b   Ulmer, Hanno ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF BERGEN   (Norway)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g CANCER REGISTRY OF NORWAY   (Norway)

^h AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

Author keywords

Cancer incidence; Lipids; Prospective study

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; AUSTRIA; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; METABOLIC SYNDROME X; NORWAY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOM ERROR; RESPIRATORY TRACT CANCER; SEX DIFFERENCE; SKIN CANCER; SWEDEN; THYROID CANCER; TRIACYLGLYCEROL BLOOD LEVEL; UTERINE CERVIX CANCER;

ADULT; ALGORITHMS; BODY MASS INDEX; COOPERATIVE BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEOPLASMS; RISK FACTORS; TRIGLYCERIDES;

EID: 79951725594     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9697-0     Document Type: Article

References (31)

1. N Sarwar J Danesh G Eiriksdottir, et al. 2007 Triglycerides and the risk of coronary heart disease: 10, 158 incident cases among 262, 525 participants in 29 Western prospective studies Circulation 115 4 450 458 1:CAS:528: DC%2BD2sXnvF2ntQ%3D%3D 10.1161/CIRCULATIONAHA.106.637793 17190864 (Pubitemid 46184196)
2. S Bansal JE Buring N Rifai S Mora FM Sacks PM Ridker 2007 Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 298 3 309 316 1:CAS:528:DC%2BD2sXotValtb0%3D 10.1001/jama.298.3.309 17635891 (Pubitemid 47080485)
3. PM Ridker 2008 Fasting versus non-fasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test? Clin Chem 54 1 11 13 1:CAS:528:DC%2BD1cXmtFemtQ%3D%3D 10.1373/clinchem.2007.097907 17998265 (Pubitemid 351182590)
4. H Iso Y Naito S Sato, et al. 2001 Serum triglycerides and risk of coronary heart disease among Japanese men and women Am J Epidemiol 153 5 490 499 1:STN:280:DC%2BD3M7otlOktA%3D%3D 10.1093/aje/153.5.490 11226981 (Pubitemid 32185086)
5. F Cambien A Jacqueson JL Richard JM Warnet P Ducimetiere JR Claude 1986 Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study Am J Epidemiol 124 4 624 632 1:STN:280:DyaL28zitVajsw%3D%3D 3752055 (Pubitemid 17178245)
6. A Fontbonne E Eschwège F Cambien, et al. 1989 Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study Diabetologia 32 5 300 304 1:STN:280:DyaL1MzisF2jtw%3D%3D 10.1007/BF00265546 2666216 (Pubitemid 19166483)
7. E Giovannucci 2007 Metabolic syndrome, hyperinsulinemia, and colon cancer: a review Am J Clin Nutr 86 3 836 842
8. E Giovannucci 2001 Insulin, insulin-like growth factors and colon cancer: a review of the evidence J Nutr 131 3109 3120
9. S Cowey RW Hardy 2006 The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169 1505 1522 1:CAS:528:DC%2BD28Xht12isr7K 10.2353/ajpath.2006.051090 17071576 (Pubitemid 351181984)
10. H Tulinius N Sigfússon H Sigvaldason K Bjarnadóttir L Tryggvadóttir 1997 Risk factors for malignant diseases: a cohort study on a population of 22, 946 Icelanders Cancer Epidemiol Biomarkers Prev 6 11 863 873 1:STN:280:DyaK1c%2Fjtl2nsA%3D%3D 9367058 (Pubitemid 27481633)
11. H Ulmer W Borena K Rapp, et al. 2009 Serum triglyceride concentrations and cancer risk in a large cohort study in Austria Br J Cancer 101 7 120 126 10.1038/sj.bjc.6605264
12. G McKeown-Eyssen 1994 Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3 8 687 695 1:STN:280:DyaK2M7oslSktA%3D%3D 7881343 (Pubitemid 24377963)
13. M Tsushima AM Nomura J Lee GN Stemmermann 2005 Prospective study of the association of serum triglyceride and glucose with colorectal cancer Dig Dis Sci 50 3 499 505 10.1007/s10620-005-2464-5 15810632 (Pubitemid 40543738)
14. J Manjer J Malina G Berglund L Bondeson JP Garne L Janzon 2001 Breast cancer risk in ex-smokers in relation to body mass index, weight gain and blood lipid levels Eur J Cancer Prev 10 3 281 287 1:STN:280:DC%2BD3MznsFyrug%3D%3D 10.1097/00008469-200106000-00013 11432717 (Pubitemid 32530374)
15. M Gaard S Tretli P Urdal 1994 Risk of breast cancer in relation to blood lipids: a prospective study of 31, 209 Norwegian women Cancer Causes Control 5 6 501 509 1:STN:280:DyaK2M7islyltA%3D%3D 10.1007/BF01831377 7827236 (Pubitemid 24335712)
16. HL Lund TF Wisloff I Holme P Nafstad 2006 Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years Am J Epidemiol 164 769 774 10.1093/aje/kwj284 (Pubitemid 44522081)
17. AJ Tande EA Platz AR Folsom 2006 The metabolic syndrome is associated with reduced risk of prostate cancer Am J Epidemiol 164 1094 1102 10.1093/aje/kwj320 16968859 (Pubitemid 44851745)
18. JR Emberson PH Whincup RW Morris M Walker GD Lowe A Rumley 2004 Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study Eur J Cardiovasc Prev Rehabil 11 2 125 134 10.1097/01.hjr.0000114967.39211.e5 15187816 (Pubitemid 38591083)
19. T Stocks W Borena S Strohmaier, et al. 2009 Cohort profile: the metabolic syndrome and cancer project (Me-Can) Int J Epidemiol 39 3 660 667 10.1093/ije/dyp186 19380371
20. W Borena T Stocks S Strohmaier, et al. 2009 Long-term temporal trends in cardiovascular and metabolic risk factors Wien Klin Wochenschr 121 19-20 623 630 10.1007/s00508-009-1238-z 19921129
21. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2001 Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 106 25 3143 3421
22. R Clarke M Shipley S Lewington L Youngman R Collins M Marmot R Peto 1999 Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 341 353 1:STN:280: DyaK1MzotFKisQ%3D%3D 10453810 (Pubitemid 29383482)
23. AM Wood I White SG Thompson S Lewington J Danesh 2006 Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27, 247 adults in 15 prospective studies Int J Epidemiol 35 1570 1578 10.1093/ije/dyl233 17148467 (Pubitemid 46178936)
24. M Inoue M Noda N Kurahashi, et al. 2009 Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan Eur J Cancer Prev 18 3 240 247 10.1097/CEJ.0b013e3283240460 19491612
25. F Al-Azzawi M Wahib 2002 Estrogen and colon cancer: current issues Climacteric 5 1 3 14 1:CAS:528:DC%2BD38XksVSru7o%3D 11974557 (Pubitemid 34309851)
26. CJ Crandall 1999 Estrogen replacement therapy and colon cancer: a clinical review J Womens Health Gend Based Med 9 1155 1166
27. JD Brunzell 2007 Clinical practice. Hypertriglyceridemia N Engl J Med 357 10 1009 1017 1:CAS:528:DC%2BD2sXhtVegsLnK 10.1056/NEJMcp070061 17804845 (Pubitemid 47367080)
28. TP Szatrowski CF Nathan 1991 Production of large amounts of hydrogen peroxide by human tumor cells Cancer Res 51 3 794 798 1:CAS:528: DyaK3MXpvFagsw%3D%3D 1846317
29. H Kamata H Hirata 1999 Redox regulation of cellular signalling Cell Signal 11 1 1 14 1:CAS:528:DyaK1MXhvF2m 10.1016/S0898-6568(98)00037-0 10206339 (Pubitemid 28546635)
30. GR Warnick K Nakajima 2008 Fasting versus nonfasting triglycerides: implications for laboratory measurements Clin Chem 54 1 14 16 1:CAS:528:DC%2BD1cXmtFemug%3D%3D 10.1373/clinchem.2007.098863 18039717 (Pubitemid 351182591)
31. G Yuan KZ Al-Shali RA Hegele 2007 Hypertriglyceridemia: its etiology, effects and treatment CMAJ 176 8 1113 1120 17420495 (Pubitemid 46649735)